Neuroprotective strategies for cognitive decline in type 2 diabetes
Trends in Endocrinology & Metabolism · 2026-11 · 37 (11) · 1088-1102
DOI: 10.1016/j.tem.2026.04.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-11. Verfasst von Flavia A Cimini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cognitive Dysfunction, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D) is increasingly associated with cognitive impairment and dementia, reflecting the combined impact of metabolic dysregulation, vascular injury, neuroinflammation, and defective brain insulin signaling. While this link is now well recognized, it remains unclear whether cognitive decline in T2D is modifiable. This review focuses on emerging neuroprotective strategies, highlighting both pharmacological and lifestyle-based interventions. Recent evidence indicates that some glucose-lowering agents, notably metformin, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists, may exert pleiotropic effects on brain metabolism, inflammation, and vascular integrity beyond glycemic control. We propose a conceptual shift in T2D management in which cognitive preservation becomes an explicit therapeutic objective, integrating metabolic control with targeted brain-protective approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
- Integrative Pharmacology and Systems Neurosciences Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
- Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
- Integrative Pharmacology and Systems Neurosciences Research Group, Hospital del Mar Research Institute, Barcelona, Spain; Faculty of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Physiopatholog…
Zitieren
APA
Cimini, F. A., Cuenca-Royo, A., Gomis-Gonzalez, M., Forcano, L., Barchetta, I., Barone, E., Cavallo, M. G., & De La Torre, R. (2026). Neuroprotective strategies for cognitive decline in type 2 diabetes. Trends in Endocrinology & Metabolism, 37(11), 1088-1102. https://doi.org/10.1016/j.tem.2026.04.003
Vancouver
Cimini FA, Cuenca-Royo A, Gomis-Gonzalez M, Forcano L, Barchetta I, Barone E, et al. Neuroprotective strategies for cognitive decline in type 2 diabetes. Trends in Endocrinology & Metabolism. 2026;37(11):1088-1102. doi:10.1016/j.tem.2026.04.003
BibTeX
@article{Cimini2026,
author = {Cimini, Flavia A and Cuenca-Royo, Aida and Gomis-Gonzalez, Maria and Forcano, Laura and Barchetta, Ilaria and Barone, Eugenio and Cavallo, Maria G and De La Torre, Rafael},
title = {Neuroprotective strategies for cognitive decline in type 2 diabetes},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
volume = {37},
number = {11},
pages = {1088--1102},
doi = {10.1016/j.tem.2026.04.003}
}
EUVIMED